Correction: LncNFYC-AS1 ameliorates Mycoplasma pneumoniae pneumonia via regulating miR- 1323

Puntos clave

• LncNFYC-AS1 significantly improves outcomes in Mycoplasma pneumoniae pneumonia.
• Key finding shows a marked change in associated biomarkers linked to disease severity.
• Analysis involved assessment of LncNFYC-AS1's influence on miR-1323 within disease pathways.
• This correction supports potential interventions targeting lncRNAs in respiratory infections.